U.S. onlyEducational navigation. Verify coverage and assistance with the official insurer, program, or treatment site.

How do I get Immgolis Intri through my insurance?

Immgolis Intri · golimumab-sldi · interchangeable IV biosimilar to Simponi Aria

Immgolis Intri coverage navigator.

FDA approved May 2026 for adult rheumatoid arthritis. Its labeled indication set is narrower than Simponi Aria, so the navigator only presents the indication that applies to this product.

New-product note: FDA approved May 15, 2026. Accord has announced U.S. commercialization; verify current product availability, payer preference and billing code before treatment.

No account, member ID, name, date of birth or email is needed. Your selections stay in this page session.

1
WHY IS THIS MEDICINE BEING GIVEN?

Choose the diagnosis / reason.

Coverage rules can change by diagnosis and sometimes by formulation.

FINANCIAL HELP

Find help with your out-of-pocket costs.

Use the official support program below to check savings, patient-assistance, or access options that may apply to you.

Accord BioPharma / AccordCares access support →
IF COVERAGE GETS STUCK

The medicine may be only part of the problem.

Use the playbook that matches what is blocking treatment, then verify the current rule with the insurer, program or treatment site.

Build a next-step plan →

Important

MedicineCostHelp is an educational navigation tool, not an insurer and not a coverage determination. Medical policies, billing codes, product preferences, availability and benefit placement can change. Sources were reviewed 2026-08-21. Verify the current official source before acting.

Build a next-step action plan →

How we review sources → · Report outdated info →